Advances and mechanisms of gut microbiota modulation in enhancing immune checkpoint inhibitor efficacy

Liqiao Chen; Baoyi Li; Menghang Zu; Rui L Reis; Subhas C. Kundu; Bo Xiao

doi:10.1016/j.semcancer.2025.06.012

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors

Rebecca Simpson, Erin R. Shanahan, Richard A Scolyer, Georgina V. Long

Article2025

MYR ameliorated MSG-induced immune dysfunction in HFD mice via modulation of gut microbiota and SCFAs metabolism

Qiaoling Su, Yang Li, Jianbo Xiao, Hui Cao, Hui Wang

Article2020

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors

Romain Daillère, Bertrand Routy, Anne‐Gaëlle Goubet, Alexandria P. Cogdill, Gladys Ferrere, Carolina Alves-Costa Silva, Aurélie Fluckiger, Pierre Ly, Yacine Haddad, Eugénie Pizzato, Cassandra Thélémaque, Marine Fidelle, Marine Mazzenga, María Paula Roberti, Cléa Melenotte, Peng Liu, Safae Terrisse, Oliver Kepp, Guido Guido Kroemer, Laurence Zitvogel, Lisa Derosa

Article2021

Gut Microbiota in Colorectal Cancer: Associations, Mechanisms, and Clinical Approaches

Cayetano Pleguezuelos‐Manzano, Jens Puschhof, Hans Clevers

Article2018

The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1

Lisa Derosa, Bertrand Routy, Guido Guido Kroemer, Laurence Zitvogel